- Home
- SNDR
as 04-24-2025 4:00pm EST
Schneider National Inc is a provider of surface transportation and logistics solutions in North America. The Company offers truckload, intermodal, and logistics services to a diverse customer base throughout the continental United States, Canada, and Mexico. The company's segments include Truckload; Intermodal; Logistics and other. It generates maximum revenue from the Truckload segment.
Upcoming Earnings Alert:
Get ready for potential market movements as Schneider National Inc. SNDR prepares to release earnings report on 01 May 2025.
| Founded: | 1935 | Country: | United States |
| Employees: | N/A | City: | GREEN BAY |
| Market Cap: | 4.8B | IPO Year: | 2017 |
| Target Price: | $27.08 | AVG Volume (30 days): | 798.4K |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.66 | EPS Growth: | -50.75 |
| 52 Week Low/High: | $20.61 - $33.90 | Next Earning Date: | 05-01-2025 |
| Revenue: | $5,290,500,000 | Revenue Growth: | -3.79% |
| Revenue Growth (this year): | 12.92% | Revenue Growth (next year): | 6.95% |
Latest Schneider National Inc. News
SNDR Breaking Stock News: Dive into SNDR Ticker-Specific Updates for Smart Investing
StockStory
2 days ago
3 Small-Cap Stocks in the Doghouse
Argus Research
2 days ago
SNDR: Rating decreased to a HOLD
MT Newswires
3 days ago
UBS Adjusts Schneider National Price Target to $25 From $32, Maintains Buy Rating
TipRanks
8 days ago
Morgan Stanley Says These 2 Sectors Can Weather Market Volatility — and Suggests 2 Stocks to Bet On
Argus Research
9 days ago
SNDR: Raising target price to $24.00
StockStory
10 days ago
3 of Wall Street’s Favorite Stocks in the Doghouse
Zacks
13 days ago
Here's Why Investors Should Give Schneider Stock a Miss Now
Argus Research
16 days ago
SNDR: Lowering target price to $23.00
Compare SNDR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SNDR Schneider National Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.